ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Accelerator Applications
The division was organized to promote the advancement of knowledge of the use of particle accelerator technologies for nuclear and other applications. It focuses on production of neutrons and other particles, utilization of these particles for scientific or industrial purposes, such as the production or destruction of radionuclides significant to energy, medicine, defense or other endeavors, as well as imaging and diagnostics.
Meeting Spotlight
2024 ANS Winter Conference and Expo
November 17–21, 2024
Orlando, FL|Renaissance Orlando at SeaWorld
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Sep 2024
Jul 2024
Latest Journal Issues
Nuclear Science and Engineering
November 2024
Nuclear Technology
Fusion Science and Technology
October 2024
Latest News
Bipartisan nuclear waste bill introduced in U.S. House
U.S. representatives Mike Levin (D., Calif.) and August Pfluger (R., Texas) have introduced the bipartisan Nuclear Waste Administration Act of 2024, which would establish an independent agency to manage the country’s nuclear waste.
In addition to establishing a new, single-purpose administration to manage the back end of the nuclear fuel cycle, the bill would direct a consent-based siting process for nuclear waste facilities and ensure reliable funding for managing nuclear waste by providing access to the Nuclear Waste Fund. According to Pfluger and Levin, the bill’s provisions are in line with recommendations from the Blue Ribbon Commission on America’s Nuclear Future.
Dale J. Merchant
Nuclear Technology | Volume 87 | Number 4 | December 1989 | Pages 1099-1105
Late Paper | TMI-2: Decontamination and Waste Management / Nuclear Reactor | doi.org/10.13182/NT89-A27700
Articles are hosted by Taylor and Francis Online.
External and internal radiation exposures to workers involved in the Three Mile Island Unit 2 recovery effort are reviewed. The 1979 accident left the plant with several areas with radiation environments that would not allow personnel entries for more than a few minutes without reaching the federal radiation limits. The recovery necessitated many unique tasks never before attempted in the U.S. commercial nuclear industry. Total commitment to the as-low-as-reasonablyachievable principle has helped keep individual and collective exposures acceptably low while allowing the recovery to proceed expeditiously. Since the initial worker actions to stabilize the plant and assess accident damage during 1979, there have been no individual exposures to radiation in excess of regulatory limits. Every individual annual dose since 1980 has been <0.04 Sv (4 rem), and the average annual worker dose has been comparable with the U.S. industry average. The annual collective exposures have been increasing since the initial plant stabilization. The relatively low collective doses from 1980 to 1983 reflect the technical planning and engineering phase of the recovery while conducting initial decontamination and dose reduction measures. Preliminary reactor vessel preparations and actual defueling commenced in 1984 and 1985. The collective doses in 1986 and 1987 correspond to the full-scale defueling and decontamination activities. The actual cumulative occupational dose through August 1988 was ∼53 person-Sv (5300 person-rem), and it is anticipated that <70 person-Sv (7000 personrem) will have been expended for the recovery. These collective doses are within the U.S. Nuclear Regulatory Commission’s original estimate of 30 to 80 person-Sv (3000 to 8000 person-rem) and compare to the average collective dose for commercial nuclear power plants in the United States over the same time period.